We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDUP icon
726
ThredUp
TDUP
$401M
$652K 0.02%
87,000
-23,000
-21% -$135K
CFBK icon
727
CF Bankshares
CFBK
$238M
$650K 0.02%
27,097
+441
+2% +$10.1K
AOSL icon
728
Alpha and Omega Semiconductor
AOSL
$998M
$646K 0.02%
25,185
+13,010
+107% +$283K
TNGX icon
729
Tango Therapeutics
TNGX
$4.72B
$640K 0.02%
125,000
– –
PAYS icon
730
Paysign
PAYS
$693M
$638K 0.02%
88,670
– –
DSGN icon
731
Design Therapeutics
DSGN
$862M
$634K 0.02%
188,200
+74,400
+65% +$278K
LIVE icon
732
Live Ventures
LIVE
$29.6M
$634K 0.02%
36,487
-9,731
-21% -$142K
CPIX icon
733
Cumberland Pharmaceuticals
CPIX
$115M
$631K 0.02%
188,355
+4,200
+2% +$19.9K
TBCH
734
Turtle Beach Corp
TBCH
$249M
$631K 0.02%
45,600
+16,000
+54% +$191K
ACRS icon
735
Aclaris Therapeutics
ACRS
$851M
$630K 0.01%
443,319
+154,600
+54% +$209K
FOSL icon
736
Fossil Group
FOSL
$344M
$629K 0.01%
425,182
+10,249
+2% +$12.9K
ASRV icon
737
AmeriServ Financial
ASRV
$81.3M
$627K 0.01%
206,177
+1,594
+0.8% +$4.11K
TREE icon
738
LendingTree
TREE
$447M
$608K 0.01%
16,398
-172
-1% -$6.95K
SMLR
739
DELISTED
Semler Scientific
SMLR
$607K 0.01%
15,676
– –
PKOH icon
740
Park-Ohio Holdings
PKOH
$670M
$604K 0.01%
33,841
-196
-0.6% -$3.71K
GENC icon
741
Gencor Industries
GENC
$212M
$598K 0.01%
42,719
+1,100
+3% +$14.4K
GOSS icon
742
Gossamer Bio
GOSS
$87.2M
$598K 0.01%
485,900
-75,000
-13% -$81.8K
CSPI icon
743
CSP Inc
CSPI
$83.2M
$597K 0.01%
46,145
– –
VNDA icon
744
Vanda Pharmaceuticals
VNDA
$308M
$593K 0.01%
125,700
– –
BKSY icon
745
BlackSky Technology
BKSY
$1.14B
$592K 0.01%
28,750
-16,700
-37% -$180K
WHWK
746
Whitehawk Therapeutics
WHWK
$232M
$590K 0.01%
315,284
– –
RGCO icon
747
RGC Resources
RGCO
$228M
$584K 0.01%
26,100
– –
FCCO icon
748
First Community Corp
FCCO
$322M
$578K 0.01%
23,716
+999
+4% +$23K
VSTS icon
749
Vestis
VSTS
$1.83B
$573K 0.01%
+100,000
New +$702K
DLTH icon
750
Duluth Holdings
DLTH
$158M
$572K 0.01%
272,579
+3,645
+1% +$6.84K
28 29
30
31 32

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.